Meropenem-resistant Burkholderia pseudomallei case in Australia
Author Information
Author(s): Sivabalan Pirathaban, Satyaputra Ferris, Gassiep Ian, Forde Brian, Frazer Jaimie, Glover Matthew, Adams Buenafe, Norton Robert
Primary Institution: Pathology Queensland, Townsville Hospital, Douglas, Townsville, Queensland, Australia
Hypothesis
Is there a meropenem-resistant sub-population of Burkholderia pseudomallei in a patient with no prior exposure to meropenem?
Conclusion
This case reports the first instance of a meropenem-resistant Burkholderia pseudomallei isolate in Australia without prior carbapenem exposure.
Supporting Evidence
- The isolate was confirmed as Burkholderia pseudomallei through molecular detection.
- Antimicrobial susceptibility testing revealed a meropenem MIC of >32 µg/ml for the resistant isolate.
- This is the first reported case in Australia of a B. pseudomallei isolate resistant to meropenem without previous exposure.
- Whole-genome sequencing did not reveal any known resistance determinants for meropenem.
Takeaway
A man in Australia got a skin infection from a germ that usually can be treated with a strong medicine called meropenem, but this germ didn't respond to it, even though he had never taken that medicine before.
Methodology
The case involved whole-genome sequencing and antimicrobial susceptibility testing of the isolate.
Limitations
The study did not completely exclude the possibility of resistance developing in vitro during susceptibility testing.
Participant Demographics
54-year-old male with type II diabetes and chronic kidney disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website